Cartesian Therapeutics Inc. (RNAC)
Market Closed
6 Jun, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary 
XBER $
11. 04
+1.7
+18.15%
$
286.41M Market Cap
- P/E Ratio
0% Div Yield
100,200 Volume
- Eps
$ 9.34
Previous Close Day Range
9.18 11.12
Year Range
8.46 41.87
Want to track RNAC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| RNAC Cartesian Therapeutics Inc. 6 May 2025 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics Inc. 5 Mar 2025 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics Inc. 11 Nov 2024 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics Inc. 15 Aug 2024 | | - Cons. EPS | 0.54 EPS |
| RNAC Cartesian Therapeutics Inc. 8 Aug 2024 | | - Cons. EPS | 0.54 EPS |
| RNAC Cartesian Therapeutics Inc. 14 Jun 2024 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics Inc. 20 May 2024 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics Inc. 2 May 2024 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics Inc. 7 Mar 2024 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics Inc. 6 Mar 2024 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics Inc. 4 Mar 2024 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics Inc. 1 Mar 2024 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics Inc. 29 Feb 2024 | | - Cons. EPS | - EPS |
2025 © Marketlog. All Rights Reserved.
